What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Pathology
- Disease
His scientific interests lie mostly in Pathology, Cerebrospinal fluid, Internal medicine, Central nervous system disease and Glial fibrillary acidic protein.
Lars Rosengren has included themes like Multiple sclerosis, Cerebral infarction and Central nervous system in his Pathology study.
His research integrates issues of Alzheimer's disease, Tau protein, Stroke and Dementia, Vascular dementia in his study of Cerebrospinal fluid.
Lars Rosengren combines subjects such as Vascular disease and Cytokine with his study of Stroke.
His Internal medicine research includes elements of Gastroenterology, Glasgow Coma Scale, Endocrinology and Cardiology.
His biological study spans a wide range of topics, including Neurology and Astrogliosis.
His most cited work include:
- Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology (373 citations)
- Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. (347 citations)
- Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. (338 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Cerebrospinal fluid, Pathology, Internal medicine, Glial fibrillary acidic protein and Endocrinology.
His Cerebrospinal fluid study incorporates themes from Neurofilament, Central nervous system disease, Immunology, Dementia and Brain damage.
His Pathology research is multidisciplinary, relying on both Multiple sclerosis and Central nervous system.
His work deals with themes such as Gastroenterology, Anesthesia and Glasgow Outcome Scale, which intersect with Internal medicine.
His research in Glial fibrillary acidic protein intersects with topics in Enolase, Gliosis, Astrogliosis and Neurofilament light.
His study explores the link between Endocrinology and topics such as Gerbil that cross with problems in Cerebellar vermis.
He most often published in these fields:
- Cerebrospinal fluid (51.14%)
- Pathology (44.89%)
- Internal medicine (38.07%)
What were the highlights of his more recent work (between 2009-2021)?
- Cerebrospinal fluid (51.14%)
- Internal medicine (38.07%)
- Pathology (44.89%)
In recent papers he was focusing on the following fields of study:
Lars Rosengren spends much of his time researching Cerebrospinal fluid, Internal medicine, Pathology, Stroke and Biomarker.
His Cerebrospinal fluid research includes themes of Progressive supranuclear palsy, Atrophy, Neurofilament, Tau protein and Parkinson's disease.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology, Depression and Immunology.
The concepts of his Pathology study are interwoven with issues in Multiple sclerosis and Central nervous system disease.
His work focuses on many connections between Central nervous system disease and other disciplines, such as Head injury, that overlap with his field of interest in Traumatic brain injury.
His Stroke research incorporates elements of Neurology and Risk factor.
Between 2009 and 2021, his most popular works were:
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. (241 citations)
- General Anesthesia Versus Conscious Sedation for Endovascular Treatment of Acute Ischemic Stroke: The AnStroke Trial (Anesthesia During Stroke). (193 citations)
- Hypotension During Endovascular Treatment of Ischemic Stroke Is a Risk Factor for Poor Neurological Outcome (103 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Enzyme
Lars Rosengren mainly investigates Cerebrospinal fluid, Pathology, Glial fibrillary acidic protein, Multiple sclerosis and Anesthesia.
His Cerebrospinal fluid study is concerned with the larger field of Internal medicine.
His Pathology study integrates concerns from other disciplines, such as White matter and Hyperintensity.
His research in Glial fibrillary acidic protein intersects with topics in Case-control study, Parkinson's disease, Differential diagnosis, Corticobasal degeneration and Intensive care unit.
His Multiple sclerosis study also includes fields such as
- Central nervous system disease, Expanded Disability Status Scale, Nerve injury, Nerve degeneration and Gliosis most often made with reference to Neurology,
- Astrogliosis which is related to area like Natalizumab.
His studies deal with areas such as Stroke, Thrombolysis, Cerebral infarction and Blood pressure as well as Anesthesia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
